121 Bio

121 Bio Overview

Founded 2013
Status Out of Business
Latest Deal Type Out of Business

121 Bio General Information


Developer of a suite of innovative research tools designed for modification of proteins and cells and innovative cellular immunotherapies. The company's research tools will help drive fundamental new discoveries in protein structure/function and through systematic and deliberate modification of proteins, providing a platform for development of protein-based drugs with enhanced performance.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Healthcare
Primary Office
  • 700 Main Street
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000

121 Bio Timeline

Date FoundedFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

121 Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-May-2017 Completed Out of Business
1. Early Stage VC (Series A) 01-Jan-2014 Completed Startup

121 Bio Executive Team (4)

Name Title Board Seat Contact Info
Vanessa Winfield Operations Manager
James Gorman Ph.D Co-Founder, Chief Executive Officer, CSO and Board Member
Gregg Beloff JD Chief Financial Officer
Ramani Varanasi Chief Business Officer

121 Bio Board Members (4)

To view 121 Bio‘s full board member team, request access »
Name Representing Role Since
Hidde Ploegh Ph.D Self Co-Founder & Board Member 000 0000
James Gorman Ph.D Self Co-Founder, Chief Executive Officer, CSO and Board Member 000 0000

2 Former Board Members

Ready to get started?

Request a free trial